Weight-loss stocks get a boost from new Biden proposal on drug coverage
Stocks of Novo Nordisk, Eli Lilly, and Viking Therapeutics rose premarket due to a proposed rule allowing Medicare to cover new obesity and diabetes drugs. This may lead to conflict between the pharmaceutical industry and Robert F. Kennedy Jr.